 | Up a level |
McMurray, John J; Holman, Rury R; Haffner, Steven M; Bethel, M Angelyn; Holzhauer, Björn; Hua, Tsushung A; Belenkov, Yuri; Boolell, Mitradev; Buse, John B; Buckley, Brendan M; Chacra, Antonio R; Chiang, Fu-Tien; Charbonnel, Bernard; Chow, Chun-Chung; Davies, Melanie J; Deedwania, Prakash; Diem, Peter; Einhorn, Daniel; Fonseca, Vivian; Fulcher, Gregory R; ... (2010). Effect of valsartan on the incidence of diabetes and cardiovascular events. New England journal of medicine NEJM, 362(16), pp. 1477-90. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa1001121
Holman, Rury R; Haffner, Steven M; McMurray, John J; Bethel, M Angelyn; Holzhauer, Björn; Hua, Tsushung A; Belenkov, Yuri; Boolell, Mitradev; Buse, John B; Buckley, Brendan M; Chacra, Antonio R; Chiang, Fu-Tien; Charbonnel, Bernard; Chow, Chun-Chung; Davies, Melanie J; Deedwania, Prakash; Diem, Peter; Einhorn, Daniel; Fonseca, Vivian; Fulcher, Gregory R; ... (2010). Effect of nateglinide on the incidence of diabetes and cardiovascular events. New England journal of medicine NEJM, 362(16), pp. 1463-76. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa1001122
Shepherd, James; Kastelein, John J P; Bittner, Vera; Deedwania, Prakash; Breazna, Andrei; Dobson, Stephen; Wilson, Daniel J; Zuckerman, Andrea; Wenger, Nanette K (2007). Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clinical journal of the American Society of Nephrology, 2(6), pp. 1131-9. Washington, D.C.: American Society of Nephrology 10.2215/CJN.04371206
